Margaret E. McLaughlin
Novartis (China)(CN)Novartis (United States)(US)
Publications by Year
Research Areas
Cancer Research and Treatments, Ovarian cancer diagnosis and treatment, Wnt/β-catenin signaling in development and cancer, Cancer Mechanisms and Therapy, Neurofibromatosis and Schwannoma Cases
Most-Cited Works
- → Prediction of central nervous system embryonal tumour outcome based on gene expression(2002)2,379 cited
- → Restoration of p53 function leads to tumour regression in vivo(2007)1,826 cited
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.(2003)
- → Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974(2013)825 cited
- → Telomerase modulates Wnt signalling by association with target gene chromatin(2009)689 cited
- → Recessive mutations in the gene encoding the β–subunit of rod phosphodiesterase in patients with retinitis pigmentosa(1993)